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2Figure S1. 1H NMR (A) and 13C NMR (B) spectra of complex 1.
3Figure S2. ROESY spectrum of the complex 1.
4Figure S3. (A)The electronic absorption spectra of the ligand H8qasesc and complex 1 (c = 5 × 
10‒5 M) in methanol. (B) UV-Vis spectroscopy data of 1 in DMSO/H2O 1 : 100 (v/v). First 
measurement (red), after 24 h (blue).
Figure S4. Cyclic voltammograms of H8qasesc (red) and 1 (black) in anhydrous DMSO 
containing 0.10 M [n-Bu4N][PF6] at scan rate of 100 mVs-1 using a glassy carbon electrode.
5Table S1. Crystal data and structure refinement for the ligand H8qasesc and complex 1
H8qasesc 1
Crystal data
Empirical formula C11H10N4Se C22H18CoN8Se2·ClO4· C2H6SO
Formula weight 277.19 788.82
Crystal system 
space group
Monoclinic
P21/c
Triclinic
P¯1
a, b, c (Å) 8.8291(8), 12.9308(8), 
10.1657(7)
10.3102 (6), 10.7772 (6), 
14.5496 (8)
, ,  (°) 90, 97.384(8), 90 80.932 (5), 89.859 (5), 65.526 
(5)
V (Å3) 1150.97 (15) 1449.47 (15)
Z 4 2
 (mm-1) 3.24 3.32
Crystal size (mm) 0.33 × 0.25 × 0.11 0.09 × 0.08 × 0.08
Data collection
 Tmin, Tmax 0.719, 1.000 0.935, 1.000
No. of measured, 
independent and
observed [I > 2(I)] 
reflections
4093
2025 
1668  
21127 
6302 
5185  
Rint 0.023 0.040
(sin /)max (Å-1) 0.594 0.639
Refinement
R[F2 > 2(F2)]
wR(F2)
S
0.031  
0.075  
1.02
0.038  
0.094  
1.02
No. of reflections 2025 6302
No. of parameters 161 389
max, min (e Å-3) 0.51, -0.36 0.65, -0.52
6Table S2. Selected geometrical parameters for H8qasesc and 1.
H8qasesc 1
Bond Distance (Å) Bond Distance (Å)
Se1–C12 1.847(3) Co1‒N2 1.924(3)
N2–C11 1.271(3) Co1‒N2a 1.928(3)
N2–N3 1.372(3) Co1‒N1a 2.025(3)
N3–C12 1.334(4) Co1‒N1 2.036(3)
N4–C12 1.315(4) Co1‒Se2 2.3267(5)
N1–C2 1.311(4) Co1‒Se1 2.3345(6)
N1–C6 1.367(3) Se1‒C12 1.879(3)
C6–C5 1.411(4) Se2‒C12a 1.882(3)
C6–C10 1.422(4) N2‒C11 1.294(4)
C2–C3 1.453(4) N2‒N3 1.397(3)
C11–C10 1.377(4) N3‒C12 1.313(4)
N4‒C12 1.334(4)
N2a‒C11a 1.295(4)
N2a‒N3a 1.399(4)
N3a‒C12a 1.309(4)
N4a‒C12a 1.342(4)
Angle (°) Angle (°)
C11–N2–N3 116.2(2) N2a‒Co1‒N2 168.08(11)
C12–N3–N2 119.9(2) N2a‒Co1‒N1a 95.77(11)
C2–N1–C6 117.1(3) N2‒Co1‒N1a 93.44(11)
N4–C12–N3 118.4(3) N2a‒Co1‒N1 93.14(11)
N4–C12–Se1 122.3(2) N2‒Co1‒N1 94.82(11)
N3–C12–Se1 119.3(2) N1a‒Co1‒N1 87.48(11)
N1–C6–C5 121.9(3) N2a‒Co1‒Se1 85.30(8)
N1–C6–C10 118.7(2) N2‒Co1‒Se2 84.04(8)
C5–C6–C10 119.3(2) N1a‒Co1‒Se2 177.20(8)
N2–C11–C10 120.8(3) N1‒Co1‒Se2 91.52(8)
C9–C10–C6 118.7(2) N2a‒Co1‒Se2 86.89(8)
N2‒Co1‒Se1 87.19(8)
N1a‒Co1‒Se1 89.69(8)
N1‒Co1‒Se1 176.61(8)
Se2‒Co1‒Se1 91.39(2)
7Table S3.  Selected dihedral angles (°) for H8qasesc.
C11–N2–N3–C12 –177.6(2)
N2–N3–C12–N4 –0.1(4)
N2–N3–C12–Se1 178.20(19)
C2–N1–C6–C5 1.6(4)
C2–N1–C6–C10 –177.6(2)
N3–N2–C11–C10 179.0(2)
N1–C6–C10–C9 –178.6(3)
C6–N1–C2–C3 –0.4(5)
N4–C8–C7–C6 177.6(3)
C10–C6–C5–C7 –3.1(4)
N1–C6–C10–C11 0.6(4)
C5–C6–C10–C11 –178.7(2)
N2–C11–C10–C9 –4.3(4)
N2–C11–C10–C6 176.5(2)
C6–C10–C9–C8 0.1(4)
C11–C10–C9–C8 –179.1(3)
N1–C6–C5–C4 –1.7(4)
C10–C6–C5–C4 177.6(2)
C7–C5–C4–C3 –178.9(3)
N1–C2–C3–C4 –0.8(5)
8Figure S5. The crystal packing of H8qasesc viewed along a-axis. Hydrogen bonds are shown as 
light blue dashed line. The molecules of H8qasesc in the crystal structure are connected to a 
head-to-tail one dimensional polymer by N4–H4B⋅⋅⋅N1 [1 ‒ x,1/2 + y,3/2 ‒ z] hydrogen bond 
(N4…N1 = 3.191(4) Å; N4–H4B = 0.80(3) Å; H4B⋅⋅⋅N1 = 2.41(3) Å; N4–H4B–N1 = 166).
9Figure S6. Crystal packing in the crystal structure of complex 1 viewed along the a-axis. Color 
code: chlorine – green, oxygen – red, cobalt - purple, nitrogen – blue, selenium – yellow, carbon 
– grey, hydrogen – white. (A) Infinite 1-D chains, formed by hydrogen bonding, parallel to the b-
axis. Perchlorate anions and solvent DMSO molecules also participate in the hydrogen bonding. 
(B) π-π stacking interactions of quinoline fragments (red dashed lines); perchlorate anions, 
DMSO solvent molecules and hydrogen atoms are omitted for clarity. The stacking interactions 
between neighboring pyridine fragments expand 1-D chains formed by hydrogen bonding into 
2-D supramolecular layers parallel to (001). Finally, these 2-D layers are further interlinked into 
a 3-D framework by additional stacking interactions.
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Table S4. Hydrogen bond and π-π stacking interaction parameters in the crystal structure of 
complex 1.
H-bond parameters
D‒H···A D‒H (Å) H···A (Å) D···A (Å) D‒H···A (°) symmetry operation on A
N4A‒H4A1···O1 0.86 2.09 2.908(4) 160
N4A‒H4A2···O4 0.86 2.13 2.978(9) 168
N4‒H41···N3 0.86 2.13 2.974(4) 169 2 ‒ x, 1 ‒ y, 1 ‒ z
N4‒H42···N3A 0.86 2.38 3.189(4) 157 2 ‒ x, ‒ y, 1 ‒ z
π-π interaction parameters
Cg(I),Cg(J)a 
Cg–Cgb (Å)
αc (°) β d (°) γ e (°) slippage f (Å) symmetry operation on J
complex 3
Cg1, Cg1
4.017(2)
0.01(1) 29.6 29.6 1.987 2 ‒ x, ‒ y, 2 ‒ z
Cg2, Cg2
4.011(2)
0.03(2) 31.5 31.5 2.097 1 ‒ x, 1 ‒ y, 1 ‒ z
a Planes of the rings I/J: ring (1) = N(1),C(2),C(3),C(4),C(5),C(10); ring (2) = N(1A),C(2A),C(3A),C(4A),C(5A),C(10A)
b Cg–Cg = distance between ring centroids (Å).
c α = dihedral angle between planes I and J (°).
d β = angle between Cg(I),Cg(J) vector and normal to plane I (°).
e γ = angle between Cg(I), Cg(J) vector and normal to plane J (°).
f Slippage = distance between Cg(I) and perpendicular projection of Cg(J) on ring I (Å).
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Figure S7.  ED50 values for CDDP and H8qasesc on THP-1 cell line.  THP-1 cells were treated 
with CDDP and H8qasesc applied in a range of six concentrations for 24 h, and afterwards 
stained with Annexin-V and PI. Percentages of all Annexin-V labeled cells for each 
concentration of investigated compounds were calculated as a proportion of the maximal 
apoptotic response normalized as 100%. Such scaled apoptotic outcomes were plotted against 
concentrations and ED50 concentration was calculated using asymmetric sigmoidal curve five-
parameter logistic equation (GraphPad Prism 6 software).
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Figure S8. Activity of 1 on THP-1 cell line. Annexin-V and propidium iodide (PI) double 
staining THP-1 cells after 24 h treatment with 1 applied in a concentration range 1-100 µM (A) 
and in a low concentration range 0.3-3 µM (B). In Annexin-V/PI plots cells are discriminated as 
viable (non-stained cells, lower left quadrant), cells in early phases of apoptosis (Annexin-V 
single stained cells, lower right quadrant), cells in late phases of apoptosis (double-stained cells, 
upper right quadrant), and cells in necrosis (PI single stained cells, upper left quadrant). Results 
are represented as a single replicate considering the second experiment was not performed due to 
the high percentage of necrotic cells induced by the treatment with 1 on this cell line.
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Figure S9. Activity of CDDP on THP-1 cell line. Annexin-V and propidium iodide (PI) double 
staining (left panels) and PI single staining (right panels) of THP-1 cells after 24 h treatment with 
CDDP applied in a range of six concentrations. In Annexin-V/PI plots cells are discriminated as 
viable (non-stained cells, lower left quadrant), cells in early phases of apoptosis (Annexin-V 
single stained cells, lower right quadrant), cells in late phases of apoptosis (double-stained cells, 
upper right quadrant), and cells in necrosis (PI single stained cells, upper left quadrant). The 
same cells evaluated with Annexin-V/PI were fixed in ethanol right after analysis, left overnight 
and afterwards assayed for distribution within phases of mitotic division with PI single staining 
method. Frequency of cells found in G0/G1, S and G2/M phases was determined according to 
non-treated control population. All results are expressed as the mean % ± SD of two replicates 
from independent experiments.
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Figure S10. Activity of caspase-8 and -9 in non-treated and treated THP-1 cells. Caspase-8 and -
9 activities were determined after 6 h incubation with H8qasesc and CDDP applied at their ED50 
concentrations. In the plots cells are discriminated as live (not stained with either caspase nor 
7-AAD), mid stage apoptotic cells (cells stained with either caspase-8 or -9, but negative to 
7-AAD), late stage apoptotic cells (cells stained with either of caspase-8 or -9 and with 7-AAD), 
and necrotic cells (cells not stained with either caspase-8 nor -9, but positive for 7-AAD). 
Results are expressed as the mean % ± SD of two replicates from independent experiments.
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Figure  S11. (A) The ligand H8qasesc in heme binding site of HSA (PDB ID 1BJ5), with 
marked amino acid residues and interactions.  The interactions in the binding pocket include 
hydrophobic/aromatic with Leu 182, Tyr 161, Phe 165, Leu 135, Phe 134 and Tyr 138. 
Hydrophilic interactions include hydrogen bonds with Tyr 161 and Leu 182 (via carbonyl 
oxygen). (B) The complex 1 in binding site of HSA, with marked amino acid residues and 
interactions. Selected conformation with the lowest binding energy (‒35.58 kJ mol‒1). The main 
electrostatic interaction is formed with Arg 209 and Lys 351, with partially negatively charged 
(and acidic) nitrogen atoms. Although the complex cation is +1 charged, the electrostatic 
interaction with Glu 354 is not formed. The rest of interactions are hydrophobic type CH‒π and 
aromatic, including interaction of residues Leu 347, Ala 210, Ala 213 and Val 482. Green: 
hydrogen bonds; Grey: hydrophobic/aromatic interactions.
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Table S5. Quantified interactions of 1 with aminoacid residues in binding site of HSA.
Residue (atom) Interaction type Distance / Å
Phe 206 (carbonyl O) Hydrogen bond 1.985
Ala 210 Hydrophobic 3.847
Ala 213 Hydrophobic 4.376
Leu 347 Hydrophobic 4.023
Leu 347 Hydrophobic 5.188
Lys 351 Hydrogen bond 3.284
Val 482 Hydrophobic 5.394
Val 482 Hydrophobic 4.729
Arg 209 (NH1)  - Nsp2 Hydrogen bond 3.372
Arg 209 (NH1)  - Se Hydrogen bond 3.462
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EXPERIMENTAL PART
Materials and methods
All the employed reagents and solvents were of analytical grade and used without further 
purification. 8-Quinolinecarboxaldehyde (8qa) was obtained from MAYBRIDGE (England), 
while cobalt(II) perchlorate hexahydrate was obtained from Aldrich (Sigma-Aldrich Chemie 
GmbH, Steinheim, Germany).
Elemental analyses (C, H, N) were performed by the standard micromethods using the 
ELEMENTARVario ELIII C.H.N.S=O analyzer. Infrared (IR) spectra were recorded on a 
Thermo Scientific Nicolet 6700 FT-IR spectrophotometer by the attenuated total reflection 
(ATR) technique in the region 4000–400 cm–1. Abbreviations used for IR spectra: vs, very 
strong; s, strong; m, medium; w, weak. UV-Visible (UV-Vis) spectra were recorded on a GBC 
Scientific Eq. PTY LTD Cintra 6 UV-Vis spectrophotometer (900‒220 nm), using samples 
dissolved in methanol. Molar conductivity measurements were performed at ambient 
temperature on the Crison Multimeter MM41. The 1D (1H and 13C) and 2D NMR spectra were 
performed on Bruker Avance 500 equipped with broad-band direct probe. All spectra were 
measured at 298 K. Chemical shifts are given on  scale relative to tetramethylsilane (TMS) as 
internal standard for 1H and 13C. Abbreviations used for NMR spectra: s, singlet; d, doublet; dd, 
double doublet; t, triplet; q, quartet; br. broad. Atom numbering used in NMR is shown in 
Scheme 1. The magnetic measurement at room temperature was performed by Evans’ method 
using a MSB-MK1 balance (Sherwood Scientific Ltd.) with Hg[Co(SCN)4] as a calibrant. Cyclic 
voltammetric measurements were performed using an electrochemical system CH Instruments 
(USA). The cell (10 mL) consisted of three-electrode system, glassy carbon electrode (inner 
diameter of 3 mm; CHI 104) an Ag/AgCl (saturated KCl) reference electrode and Pt counter 
electrode. The potential was swept over the range from ‒2.0 to +1.2 V (vs. Ag/AgCl) at scan rate 
of 100 mVs‒1. Measurements were performed at room temperature with deaeration of solutions 
by passing a stream of nitrogen through the solution for 5 min prior to the measurement and then 
maintaining a blanket atmosphere of nitrogen over the solution during the measurement. The 
potentials were measured in 0.10 M [n-Bu4N]PF6 /DMSO, and are quoted relative to Ag/AgCl 
reference electrode.
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Synthesis of the ligand H8qasesc
The ligand H8qasesc was synthesized according to the reported procedure [S1]. Its 
structure was confirmed by elemental analysis, IR and NMR spectroscopy. Single crystals of 
H8qasesc suitable for X-ray analysis were obtained by slow diffusion of ethanol into its DMSO 
solution of the ligand. 
H8qasesc: Anal. Calcd. for C11H10N4Se (MW = 277.18): C, 47.66; H, 3.64; N, 20.21. 
Found: C, 47.81; H, 3.82; N, 20.12 %.  IR (ATR, cm−1): 3363, 3268, 3124, 3030, 2976, 1603, 
1572, 1535, 1499, 1472, 1392, 1336, 1263, 1104, 1032, 946, 830, 785, 636, 594. 1H NMR (500 
MHz, DMSO-d6) δ (ppm): 7.60 (dd, 1H, H–C3, 3J3,4  = 8.3 Hz, 3Ј3,2 = 4.2 Hz), 7.65 (t, 1H, H–C6, 
3J6,7 = 3J6,5 = 7.7 Hz), 8.06 (dd, 1H, H–C5, 3J5,6 = 7.7 Hz, 4J5,7 = 1.2 Hz), 8.42 (dd, 1H, H–C4, 
3J4,3 = 8.3 Hz, 4J4,2 = 1.7 Hz), 8.63 (s, 1H, Ha–N4), 8.66 (dd, 1H, H–C7, 3J7,6 = 7.7 Hz, 4J7,5 = 1.2 
Hz), 8.70 (s, 1H, Hb–N4), 8.97 (dd, H–C2, 3J2,3 = 4.1 Hz, 4J2,4 = 1.7 Hz), 9.44 (s, 1H, H–C9), 
11.96 (s, 1H, H–N3). 13C NMR (126 MHz, DMSO-d6) δ (ppm): 121.82 (C3), 126.34 (C6), 
126.40 (C7), 127.96 (C4a), 130.05 (C5), 131.00 (C8), 136.59 (C4), 140.61 (C9), 145.43 (C8a), 
150.43 (C2), 173.89 (C10).
Synthesis of the complex [Co(8qasesc)2]ClO4×DMSO (1)
Into the suspension of 8-quinolinecarboxaldehyde (0.10 g, 0.63 mmol) and 
selenosemicarbazide (0.09 g, 0.64 mmol) in ethanol (10 mL), solid Co(ClO4)2×6H2O (0.12 g, 
0.32 mmol) was added. The reaction mixture was stirred under the reflux for 2 h. Brown 
microcrystalline product was filtered off and washed with cold ethanol and diethyl ether. Dark 
brown single crystals of 1 were obtained by slow diffusion of ethanol into the DMSO solution of 
the complex. Yield: 0.16 g (52.6%). Anal. Calcd. for C24H24N8O5Se2SClCo (MW = 788.86): C, 
36.54; H, 3.07; N, 14.20; S, 4.06. Found: C, 36.72; H, 3.12; N, 14.12; S, 4.12 %.  IR (ATR, 
cm−1): 3405, 3293, 3112, 1643, 1621, 1595, 1496, 1385, 1323, 1260, 1184, 1093, 913, 830, 779, 
708, 655, 623, 584, 553, 525, 460, 418. 1H NMR (500 MHz, DMSO-d6) δ (ppm): 2.54 (s, 3H, 
DMSO), 7.30 (s, 2H, H–N4), 7.60 (dd, 1H, H–C3, 3J3,4 = 8.1 Hz, 3J3,2 = 5.3 Hz), 7.96 (t, 1H, H–
C6, 3J6,5 = 3J6,7 = 7.6 Hz), 8.35 (dd, 1H, H–C5, 3J5,6 = 7.6 Hz, 4J5,7 = 1.3 Hz), 8.45 (dd, 1H, H–C7, 
3J7,6 = 7.6 Hz, 4J7,5 = 1.1 Hz), 8.66 (dd, 1H, H–C4, 3J4,3 = 8.1 Hz, 4J4,2 = 1.4 Hz), 8.72 (dd, 1H, H–
C2, 3J2,3 = 5.3 Hz, 4J2,4 = 1.4 Hz), 9.03 (s, 1H, H–C9). 13C NMR (126 MHz, DMSO-d6) δ (ppm): 
40.42 (DMSO), 123.14 (C3), 127.96 (C6), 128.92 (C8), 130.01 (C4a), 134.08 (C5), 138.61 (C7), 
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138.69 (C8a), 140.67 (C4), 155.00 (C2 and C9), 167.86 (C10). ΛM (1·10−3 M, DMSO): 32.1 Ω−1 
cm2 mol−1. UV-Vis (MeOH), λmax, nm (ε, M‒1 cm‒1): 246 (36603), 320 (20176), 386sh (11848), 
438sh (6937). Magnetic measurements showed that obtained complex is diamagnetic.
Structure determination and refinement 
A suitable single crystal of H8qasesc ligand and its Co(III) complex were mounted on a 
glass ﬁber and crystallographic data were collected using an Oxford Diffraction Gemini S 
diffractometer with a CCD area detector (MoKα = 0.710689 Å, monochromator: graphite). The 
CrysAlisPro and CrysAlis RED software packages [S2] were used for data collection and data 
integration. Collected data were corrected for absorption effects by using an Multi-scan 
absorption correction [S3]. Structure solution and reﬁnement were carried out with the programs 
SHELXS and SHELXL-2014/7, respectively [S4]. All non-hydrogen atoms were refined 
anisotropically until convergence was reached. The hydrogen atoms were located in a difference 
Fourier map and refined isotropically, with the exception of those H atoms linked to the C atoms 
and those H atoms linked to the N atoms which were placed in calculated positions (C‒H = 0.97 
Å, N‒H = 0.86 Å, Uiso values equal to 1.2 Ueq C, N) and allowed to ride on their carrier atoms. In 
1, the solvent molecule (DMSO) is disordered over two positions and therefore the hydrogen 
atoms of the crystalline solvent were not positioned and refined. CCDC 1471189 and CCDC 
1401687 contain the supplementary crystallographic data for the ligand H8qasesc and complex 
1, respectively. This data can be obtained free of charge via 
https://summary.ccdc.cam.ac.uk/structure-summary-form, or from the Cambridge 
Crystallographic Data Centre, 12 Union Road, Cambridge CB2 IEZ, UK; fax: (+044)1223-336-
033; or e-mail: deposit@ccdc.cam.ac.uk.
Free radical-scavenging activity 
The proton donating ability was assayed using the protocol for determination of radical 
scavenging activity [S5]. Compounds were dissolved in pure DMSO and were diluted into ten 
different concentrations. Commercially-available free radical 1,1-diphenyl-2-picryl-hydrazyl 
(DPPH) was dissolved in methanol at concentration 6.58 × 10–5 M. Into a 96-well microplate, 
20
140 μL of DPPH solution was loaded and 10 μL DMSO solution of the tested compounds was 
added, or pure DMSO (10 μL) as the control. The microplate was incubated for 30 min at 25 °C 
in the dark and the absorbance was measured at 517 nm using Thermo Scientific Appliskan. All 
the measurements were carried out in triplicate. Free radical scavenging activity was calculated 
using the following equation:
Scavenging activity (%) =_______________
Acontrol - Asample
Acontrol
x 100
Asample and Acontrol refer to the absorbances at 517 nm of DPPH in the sample and control 
solutions, respectively.
Cell cultures and conditions
Acute monocytic leukemia cell line (THP-1, ATCC® TIB-202) and pancreatic 
adenocarcinoma cell line (AsPC-1, ATCC® CRL-1682) were maintained in RPMI-1640 (Life 
Technologies, 11875-093) and DMEM high glucose (Sigma-Aldrich, D5796) cell culture media, 
respectively.  Both media were supplemented with 10% (v/v) fetal bovine serum (FBS, Gibco, 
Cat. No. 16000-036) and 1% (v/v) penicillin-streptomycin (10 000 units/mL and 10 000 µg/mL, 
Gibco, Cat. No. 15140-130). Cells were kept at 37 °C in atmosphere containing 5% (v/v) CO2 
during their exponential growth and during the course of experimental treatments. Investigated 
compounds were initially dissolved in DMSO to the stock concentration of 20 mM. Further 
dilutions to the experimental concentrations applied on the cells have been done with RPMI-
1640 or DMEM media immediately before each experiment, thus the final concentration of 
DMSO on cells treated with the highest applied concentration was 0.5% (v/v).
Determination of pro-apoptotic activity
THP-1 and AsPC-1 cells were seeded in 96 flat bottom well plates (Corning® Costar®, 
Cat. No. CLS3596) in 0.1 mL, at a density of 10 000 per well. Since THP-1 cells grow in 
suspension, experimental treatments started within 2 h after cells seeding, while plates with 
seeded AsPC-1 cells were left overnight to settle. Investigated compounds were added in a range 
of six concentrations. As controls, we used non-treated cells, cells treated with 0.5% DMSO, and 
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cells treated by Celastrol (Enzo Life Sciences, Cat. No. ALX-350-332-M025) at 50 µM 
concentration. After 24 h of incubation, THP-1 cells were centrifuged (RCF = 450g, 10 min), 
supernatants were discarded, and 0.1 mL of phosphase buffer saline (PBS) was added to each 
well. Plates were placed on plate shaker for 3 min, afterwards Annexin-V‒FITC (ImmunoTools, 
Cat. No. 31490013) and propidium iodide (PI, Miltenyl Biotec, Cat. No. 130-093-233) were 
added in a volume of 3 µL per well, respectively, and incubated for 15 min in the dark before 
cytometry analysis. Post incubation manipulation with AsPC-1 cells included trypsinization (200 
µL of trypsin per well, Sigma-Aldrich, Cat. No. T3924). Subsequent steps with addition of PBS, 
Annexin-V and PI were the same as for THP-1 cells. Plates were analyzed on Guava EasyCyteTM 
micro-capillary flow cytometer (EMD Millipore, Darmstadt, Germany) using InCyte® software 
package (EMD Millipore, Cat. No. 0500-4120). Cells were classified according to Annexin-V 
and PI labeling on viable (non-stained cells), pre-apoptotic cells (stained with Annexin-V only), 
cells in late phases of apoptosis (double stained cells), and necrotic cells (stained with PI only). 
After analysis, remaining cells were fixed in ethanol overnight at 4 °C, stained with FxCycleTM 
PI/RNAse Staining solution (Molecular Probes, Cat. No. F10797), then analyzed as described 
previously [S6].
Calculation of ED50 concentrations
Separately for THP-1 and AsPC-1 cells, percent of Annexin-V labeled cells for each 
investigated concentration of compounds were summarized and maximum apoptotic response 
was normalized to 100%. Percent of apoptosis read out for other concentrations were calculated 
as a proportion of the highest response. Such scaled apoptotic outcomes were plotted against 
concentrations and ED50 concentration was calculated using asymmetric sigmoidal curve five-
parameter logistic equation (GraphPad Prism 6 software). Obtained ED50 concentrations values 
of both compounds were applied in further steps of this investigation.
Inhibition of caspase activity
Cells were treated with investigated compound at ED50 concentration for 6 h with or 
without pan-caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp(OMe) fluoromethyl ketone (Z-
VAD-fmk, Promega, Cat. No. G7232). As controls, non-treated cells, cells treated with Z-VAD-
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fmk only, and cells treated with ED50 concentration only were used. After incubation period was 
ended, samples with treated cells were carried out for Annexin-V/PI staining as described above 
then monitored on Guava EasyCyteTM cytometer. The percent of apoptosis inhibited by Z-VAD-
fmk co-treatment was computed by the formula:
Inhibition, % = [1 – (% of apoptosis in A / % of apoptosis in B)] x 100,
where A is the sample treated with both ED50 and Z-VAD-fmk, while B is the corresponding 
sample treated with ED50 only.
Evaluation of caspase-8 and -9 activities
Cells treated with investigated compound at ED50 concentration for 6 h afterwards 
activity of caspase-8 and -9 were assayed by means of Guava Caspase 9 SR and Caspase 8 FAM 
kit (EMD Millipore, Cat. No. 4500-0640), following manufacturer’s instructions. In acquired 
data cells were discriminated according to expression of green fluorescence (caspase-8), yellow 
fluorescence (caspase-9), or red fluorescence (7-AAD) as the following: live cells (not stained 
with either caspase nor 7-AAD); mid-stage apoptotic cells (cells stained with either caspase-8 or 
-9, but negative to 7-AAD); late stage apoptotic cells (cells stained with either of caspase-8 or -9 
and with 7-AAD); necrotic cells (cells not stained with either caspase-8 nor -9, but positive for 7-
AAD).
Investigation of pro-differentiation activity
AsPC-1 cells were seeded in a volume 0.1 mL, at density 5000 per well of 96 well flat 
bottom plates. After 24 h, H8qasesc and 1 were added in a volume of 0.2 mL to the final 
concentrations of 1 and 10 µM per well. Wells with control cells were supplemented with 
medium up to the volume of 0.3 mL. All cells, treated and non-treated controls, were incubated 
for another 72 h, afterwards evaluation of changes in expression of cell surface markers of 
differentiation has been performed. In brief, when incubation was ended, supernatant was 
discarded after plate centrifugation for 10 min at RCF of 450g. A 0.1 mL of PBS was added to 
each well, plate was put on a plate shaker for 5 min, after anti-CD44-FITC (Miltenyl Biotec, Cat 
No 130-095-195) and anti-CD-133-PE (Miltenyl Biotec, Cat No 130-181-801) were added in a 
volume of 1 µM to each well. Non-treated controls were labeled with anti-CD44-FITC, anti-
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CD133-PE, anti-IgG-FITC (Miltenyl Biotec, Cat No 130-093-192), or anti-IgG-PE (Miltenyl 
Biotec, Cat No 190-93-193). Plates incubated at 37 °C for 30 min, were additionally washed 
with PBS to remove excess of antibodies. The plate was then monitored on Guava EasyCyteTM 
micro-capillary flow cytometer for green and yellow fluorescence intensities. Results were 
analyzed using FlowJo version X software package.
DNA plasmid interactions
For DNA cleavage experiments the plasmid pUC19 (2686 bp, purchased from Sigma-Aldrich, 
USA) was prepared by its transformation in chemically competent cells Escherichia coli strain 
XL1 blue. Amplification of the clone was done according to the protocol for growing E. coli 
culture overnight in LB medium at 37 °C [S7] and purification was performed using Qiagen 
Plasmid plus Maxi kit. Finally, DNA was eluted in 10 mM Tris-HCl buffer and stored at −20 °C. 
The concentration of plasmid DNA (460 ng/µL) was determined by measuring the absorbance of 
the DNA-containing solution at 260 nm. One optical unit corresponds to 50 µg/mL of double 
stranded DNA.
The cleavage reaction of supercoiled pUC19 DNA due to different treatments was 
investigated by incubation of 460 ng of plasmid in a 20 µL reaction mixture which contained 
variable volumes of 1 and H8qasesc previously dissolved in DMSO to the stock concentration of 
10 mM and 40 mM bicarbonate buffer (pH 8.4) at 37 °C, for 90 minutes. The reaction mixtures 
were vortexed from time to time. The reaction was terminated by short centrifugation RCF of 
6708 × g and addition of 5 µL of loading buffer (0.25% bromophenol blue, 0.25% xylene cyanol 
FF and 30% glycerol in TAE buffer, pH 8.24 (40 mM Tris-acetate, 1 mM EDTA)).
The samples were subjected to electrophoresis on 1% agarose gel (Amersham Pharmacia-
Biotech, Inc) prepared in TAE buffer pH 8.24. The electrophoresis was performed at a constant 
voltage (80 V) until bromophenol blue had passed through 75% of the gel. A Submarine Mini-
gel Electrophoresis Unit (Hoeffer HE 33) with an EPS 300 power supply was used. After 
electrophoresis, the gel was stained for 30 min by soaking it in an aqueous ethidium bromide 
solution (0.5 µg/mL). The stained gel was illuminated under a UV transilluminator Vilber-
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Lourmat (France) at 312 nm and photographed with a Nikon Coolpix P340 Digital Camera 
through filter DEEP YELLOW 15 (TIFFEN, USA). 
Molecular docking studies 
Randomly chosen X-ray crystal structures of dodecamer d(CGCGAATTCGCG)2, PDB 
ID: 3U2N [S8] and human serum albumin (HSA), PDB ID: 1BJ5 [S9], were obtained from the 
Protein Data Bank (http://www.rcsb.org/pdb). The active sites were identified according to 
positions of crystallized ligands in the PDB structures. Ligands were removed, as well as water 
and ions and structures were prepared for docking using Autodock Tools 1.5.6. [S10,S11]. 
Docking was carried in Autodock Vina 1.1.2. [S12]. Grid box size was set to 24 × 24 × 24 Å and 
exhaustiveness to 250. All calculations were carried on PARADOX computer cluster (Scientific 
Computing Laboratory of the Institute of Physics, Belgrade, Serbia). The ligand H8qasesc and 1 
were prepared using X-ray determined coordinates, with Gasteiger charge correction done with 
Chimera program [S13], as no charges were assigned for selenium atoms.
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